Research-Grade Biosimilar Antibodies from Absolute Antibody

• Direct contact technical support
• Find products for your research

These biosimilar monoclonal antibodies are essential tools for researchers who want to study biological processes without the high costs and regulatory hurdles associated with therapeutic-grade biologics.

Why Choose Research-Grade Biosimilars?

Absolute Antibody’s biosimilars are recombinantly produced to match the variable region sequence of the original therapeutic antibody. Unlike clinical-grade products, these research-grade antibodies are free from unnecessary excipients and additives, making them ideal for experimental applications. This streamlined formulation reduces the need for extensive controls, saving you time and resources in the lab.

Extensive Research-Grade Biosimilar Antibody Catalog

Their catalog includes a wide range of biosimilar antibodies, such as Trastuzumab, Gemtuzumab, Rituximab, Infliximab, Daclizumab, Basiliximab, Cetuximab, and Eculizumab. Each biosimilar is available in the original human format, and can be customized with mouse, rabbit, rhesus monkey, or cynomolgus monkey constant domains to suit your research needs.

Product Features and Benefits

• Ideal Controls: Use as controls to benchmark new biotherapeutics and develop potency assays.
• High Quality: Each antibody is supplied in PBS buffer with preservative, with endotoxin levels below 1.0 EU/mg and purity above 96%.
• Flexible Formats: Choose from a variety of species formats to match your experimental system.

Carrier-Free CONJUmAbs for ADC Research

For researchers working on Antibody Drug Conjugates (ADC), Absolute Antibody offers CONJUmAbs—carrier-free, concentrated biosimilar antibodies designed for efficient conjugation. These products are available off-the-shelf for Trastuzumab, Gemtuzumab, and Cetuximab, with other biosimilars available upon request.

Key Features of CONJUmAbs

• Concentrated: 5 mg/ml for direct use in conjugation workflows.
• Ultra-Pure: >99% purity and >98% monomer content.
• Low Endotoxin: <0.5 EU/mg, suitable for both in vivo and in vitro applications.
• Carrier-Free: No Proclin 300, sodium azide, BSA, or other excipients.

Discover More

Interested in linkers for ADC development? Explore the BioDesign™ range from Vector Laboratories for high-quality linkers and bioconjugation solutions.

Contact your account manager today for more information or to discuss your specific antibody requirements. As your trusted antibody supplier in the Benelux, Bio-Connect is here to support your research with the latest antibody technologies.

Please note: All research-grade biosimilar antibodies are intended for research use only and are not for therapeutic applications.